findmyKOL

Eric Van Cutsem, MD, PhD

Enriched profile

Emeritus Professor Doctor (em. prof. dr.); Gastroenterologist and Digestive Oncologist; Head, Division of Digestive Oncology, University Hospitals Leuven (since 2001); Professor Emeritus, KU Leuven (since October 2023) · University Hospitals Leuven (UZ Leuven)

ORCID↗NPINone on file
✓ Full profile
Region🇧🇪 BelgiumSpecialtyMedical OncologyFocusColorectal Cancer Treatments and Studies+4
Active KOLLatest publication2026Online presenceverified 2026PaymentsNot attributedNIH fundingNone on fileWhy? →

Eric Van Cutsem is Emeritus Professor Doctor (em. prof. dr.); Gastroenterologist and Digestive Oncologist; Head, Division of Digestive Oncology, University Hospitals Leuven (since 2001); Professor Emeritus, KU Leuven (since October 2023) at University Hospitals Leuven (UZ Leuven). OpenAlex indexes 1,845 publications with 176,402 citations (h-index 177); ClinicalTrials.gov lists 14 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 16 Oct 2026

Eric Van Cutsem is Emeritus Professor Doctor (em. prof. dr.) at University Hospitals Leuven (UZ Leuven) / KU Leuven, Belgium. The public record shows 1,845 publications with 176,402 citations (h-index 177), centered on Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Cancer Treatment and Pharmacology. It also documents an investigator role on 14 registered clinical trials.

  • Most recent indexed publication: 2026 · Journal of clinical oncology
  • Top research focus: Colorectal Cancer Treatments and Studies
  • 14 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Colorectal Cancer11 trialsRectal Neoplasms11 trialsNeoplasm Metastasis2 trialsGastroesophageal Cancer1 trialPancreatic Cancer1 trialStomach Neoplasms1 trialLung Cancer (NSCLC/SCLC)

Research focus

OpenAlex concept fingerprint
Colorectal Cancer Treatments and StudiesGastric Cancer Management and OutcomesCancer Treatment and PharmacologyLung Cancer Treatments and MutationsColorectal Cancer Surgical Treatments

Drugs & molecules

across trials, industry payments and publications
CetuximabClinical trials3Industry payments—Publications9PaclitaxelClinical trials2Industry payments—Publications7GemcitabineClinical trials1Industry payments—Publications6IrinotecanClinical trials2Industry payments—Publications4FluorouracilClinical trials2Industry payments—Publications3BevacizumabClinical trials1Industry payments—Publications2FolfoxClinical trials2Industry payments—Publications1LeucovorinClinical trials1Industry payments—Publications2PembrolizumabClinical trials1Industry payments—Publications2TrifluridineClinical trials1Industry payments—Publications2OxaliplatinClinical trials1Industry payments—Publications1FOLFIRI RegimenClinical trials3Industry payments—Publications—

Works with

trial sponsors and companies reporting payments
Universitaire Ziekenhuizen KU LeuvenClinical trials5Industry payments—Celyad Oncology SAClinical trials2Industry payments—Association Européenne de Recherche en OncologieClinical trials1Industry payments—AstraZenecaClinical trials1Industry payments—Celgene CorporationClinical trials1Industry payments—GamaMabs PharmaClinical trials1Industry payments—Medical Device Works NV SAClinical trials1Industry payments—Merck KGaA, Darmstadt, GermanyClinical trials1Industry payments—PfizerClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,845publications

Distinct works indexed by OpenAlex, matched via ORCID; 36 in PubMed.

176,402citations

Total citations across indexed works.

177h-index

Hirsch index (OpenAlex). i10-index 850.

Clinical & industry

trials, payments and federal funding
14clinical trials

Investigator role on registered studies.

View trials ↓
—payment companies

Not shown. No U.S. clinical registration on file.

0NIH grants

Federally funded research awards.

Public positions

sourced statements on record

This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →

Contact

An office address from a public listing. This research profile has no federal registry record to draw from.

Office address

Herestraat 49, 3000 Leuven, Belgium

From the cited public source.Collected 16 Oct 2026.View source ↗

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:

All 14 trial records: search, sort and filter.Explore →

Industry payments

Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 36 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
    7,299 citations2010
    doi.org ↗
  2. 02
    Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
    6,671 citations2013
    doi.org ↗
  3. 03
    Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
    5,049 citations2004
    doi.org ↗
  4. 04
    Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
    3,869 citations2009
    doi.org ↗
  5. 05
    ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
    3,454 citations2016
    doi.org ↗
All 1,845 cited works: search, sort and filter.Explore →

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Other

    kuleuven.academia.edu/EVanCutsem

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kuleuven.academia.edu ↗
  • Other

    bjmo.be/podcasts/prof-dr-eric-van-cutsem-about-the-highlights-from-esmo-world-congress-on-gastrointestinal-cancer

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bjmo.be ↗
  • ResearchGate

    researchgate.net/profile/Eric-Van-Cutsem

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • ResearchGate

    researchgate.net/profile/Eric-Van-Cutsem-2

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/dice_europe/status/1465623760187400192

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • X / Twitter

    x.com/myESMO/status/1146363651621826560

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • X / Twitter

    x.com/myESMO/status/1759125659681529959

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • X / Twitter

    x.com/myESMO/status/1767464342872596591

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • LinkedIn

    be.linkedin.com/in/eric-van-cutsem-3a7701a

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →be.linkedin.com ↗
  • LinkedIn

    linkedin.com/in/eric-van-cutsem-3a7701a

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • X / Twitter

    x.com/myESMO/status/1168808721306259457

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

Mentions by others

where others cite or feature them
  • X / Twitter

    ESMO (@myESMO) X post naming Eric Van Cutsem as Scientific Co-Chair of #ESMOGI24

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • X / Twitter

    ESMO (@myESMO) X post: Eric Van Cutsem among ESMO 2019 award winners

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • X / Twitter

    ESMO (@myESMO) X post: Eric Van Cutsem at #WorldGI2019 opening on GI cancer challenges

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • X / Twitter

    Digestive Cancers Europe (@dice_europe) X post referencing Prof. Dr. Eric Van Cutsem

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →twitter.com ↗
  • X / Twitter

    Celyad Oncology X post: Prof. Dr. Eric Van Cutsem presented SHRINK/alloSHRINK Phase 1 data at ESMO WCGIC

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Extraordinary Professor

    KU Leuven

    2005
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kuleuven.be ↗
  • PhD

    University of Leuven (KU Leuven)

    1994
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →digestivecancers.eu ↗
  • MD (Doctor of Medicine)

    University of Leuven (KU Leuven)

    1983
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →digestivecancers.eu ↗
  • MD (Doctor of Medicine)
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →digestivecancers.eu ↗
  • PhD
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →digestivecancers.eu ↗

Editorial & leadership roles

journal and society appointments
  • Board Member

    European Cancer Organisation

    2027
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →europeancancer.org ↗
  • Former member

    ESMO Executive Board

    2011
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esmo.org ↗
  • Head

    Division of Digestive Oncology, University Hospitals Leuven

    2001
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uzleuven.be ↗
  • Medical Director and Co-Founder

    Digestive Cancers Europe (DICE)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →digestivecancers.eu ↗
  • Editorial board member

    Annals of Oncology (ESMO)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →esmo.org ↗
  • Co-founder and Chair

    ESMO World Congress on Gastrointestinal Cancer (WCGIC)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →digestivecancers.eu ↗
  • Medical Director and Co-Founder

    Digestive Cancers Europe (DiCE) / EuropaColon

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →digestivecancers.eu ↗
  • President

    Belgian Foundation against Cancer (Stichting tegen Kanker / Fondation contre le Cancer)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →digestivecancers.eu ↗
  • President

    European Society of Digestive Oncology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →digestivecancers.eu ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Board Member (vice-president since 09-2023)

    regional hospital of Halle

    2023
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →digestivecancers.eu ↗
  • Board member

    Faculty of Medicine, KU Leuven

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →digestivecancers.eu ↗
  • Board Member

    Faculty of Medicine, KU Leuven

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kuleuven.be ↗
  • Member

    Belgian Royal Academy of Medicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →digestivecancers.eu ↗
  • President

    Belgian Foundation against Cancer

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →europeancancer.org ↗
  • Member

    CUROZ hospital network board

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →digestivecancers.eu ↗
  • Medical Director

    EuropaColon

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →europeancancer.org ↗
  • Member

    Scientific Advisory Boards for Institut National du Cancer (France), University of Ulm & Leipzig (Germany), Humanitas Hospital (Milan, Italy)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →europeancancer.org ↗
  • Executive Board Member

    EORTC (European Organisation for Research and Treatment of Cancer)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →europeancancer.org ↗
  • Executive Board Member

    ESMO (European Society for Medical Oncology)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →europeancancer.org ↗
  • Chair

    ESMO GI / Co-founder and Chair, ESMO/World Congress on Gastrointestinal Cancer

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →digestivecancers.eu ↗
  • President

    European Society for Digestive Oncology (ESDO)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →digestivecancers.eu ↗
  • Committee member

    UEG (United European Gastroenterology), ASCO, ESO (European School of Oncology)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →europeancancer.org ↗
  • Member

    LKI - KU Leuven Cancer Institute

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kuleuven.be ↗
  • Head of Pentalfa (KU Leuven continuing medical education)
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kuleuven.be ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.